Rogers
ROG
153.96
-2.64
-1.69%
Rogers
US · ROG
#2532 by market cap
Listed 1970
153.96
-2.64
-1.69%
Live - 5344 symbols - heartbeat 108s ago
· 2026-10-08 07:38
Pre-market
153.16
-0.52%
After-hours
153.96
0.00%
- Market cap
- 2.75B
- P/E (TTM)i
- 91.10
- P/Bi
- 2.28
- EPSi
- -3.40
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on ROG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.33% YoY
Margins
- Gross margin
- 31.67%
- Operating margin
- 6.43%
- Net margin
- -7.62%
Key ratios & quality
- Altman Z-Scorei
- 9.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 879.09M | 898.26M | 802.58M | 932.90M | 971.20M | 908.40M | 830.10M | 810.80M |
| Gross profit | 310.78M | 314.29M | 291.82M | 349.10M | 321.00M | 307.10M | 277.10M | 256.80M |
| Selling & admin expenses | 164.05M | 168.68M | 182.28M | 193.10M | 218.80M | 202.30M | 193.40M | 176.60M |
| Research & development | 33.08M | 31.69M | 29.32M | 29.90M | 35.20M | 35.70M | 34.60M | 28.10M |
| Operating profit | 110.71M | 112.02M | 80.36M | 126.10M | 67.00M | 69.10M | 49.10M | 52.10M |
| Pretax profit | 110.59M | 55.13M | 68.53M | 126.30M | 140.40M | 76.30M | 34.30M | -45.10M |
| Tax | 22.94M | 7.81M | 18.54M | 18.20M | 23.80M | 19.70M | 8.20M | 16.70M |
| Net profit | 87.65M | 47.32M | 49.99M | 108.10M | 116.60M | 56.60M | 26.10M | -61.80M |
| Basic EPS | 5 | 3 | 3 | 6 | 6 | 3 | 1 | -3 |
| Diluted EPS | 4.70 | 2.53 | 2.67 | 5.73 | 6.15 | 3.03 | 1.40 | -3.40 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 190.50M | 202.80M | 216.00M | 201.50M | 200.50M | 216.80M |
| Gross profit | 57.00M | 64.00M | 72.30M | 63.50M | 64.60M | 70.40M |
| Selling & admin expenses | 44.50M | 48.50M | 41.60M | 42.00M | 41.20M | 42.20M |
| Research & development | 7.10M | 7.00M | 7.40M | 6.60M | 6.70M | 7.30M |
| Operating profit | 5.60M | 8.60M | 22.80M | 15.10M | 16.60M | 20.70M |
| Pretax profit | -1.60M | -69.30M | 16.30M | 9.50M | 11.30M | 21.40M |
| Tax | -200.00K | 4.30M | 7.70M | 4.90M | 6.80M | 7.80M |
| Net profit | -1.40M | -73.60M | 8.60M | 4.60M | 4.50M | 13.60M |
| Basic EPS | 0 | -4 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.08 | -4.00 | 0.48 | 0.26 | 0.25 | 0.76 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 485.79M | 464.10M | 474.18M | 584.07M | 659.90M | 526.90M | 493.90M | 500.00M |
| Cash & ST investments | 167.74M | 166.85M | 191.79M | 232.30M | 235.90M | 131.70M | 159.80M | 197.00M |
| Inventory | 132.64M | 132.86M | 102.36M | 133.38M | 182.40M | 153.50M | 142.30M | 125.00M |
| Total assets | 1.28B | 1.27B | 1.26B | 1.60B | 1.65B | 1.52B | 1.48B | 1.43B |
| Total current liabilities | 107.18M | 100.23M | 111.51M | 163.95M | 142.50M | 116.40M | 123.50M | 126.10M |
| Short-term debt | -- | -- | -- | 198.00K | 2.80M | 3.50M | 4.00M | 3.90M |
| Long-term debt | 228.48M | 123.00M | 25.00M | 190.00M | 215.00M | 30.00M | -- | -- |
| Total liabilities | 431,020,000.00 | 339,281,000.00 | 243,250,000.00 | 479,671,000.00 | 473,700,000.00 | 258,200,000.00 | 229,500,000.00 | 234,200,000.00 |
| Total equity | 848.32M | 933.90M | 1.02B | 1.12B | 1.17B | 1.26B | 1.25B | 1.20B |
| Retained earnings | 776.40M | 823.70M | 873.69M | 981.83M | 1.10B | 1.16B | 1.18B | 1.12B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 502.90M | 500.10M | 505.00M | 500.00M | 511.40M | 543.60M |
| Cash & ST investments | 175.60M | 157.20M | 167.80M | 197.00M | 195.80M | 211.40M |
| Inventory | 143.00M | 151.20M | 142.90M | 125.00M | 127.50M | 130.00M |
| Total assets | 1.51B | 1.45B | 1.45B | 1.43B | 1.43B | 1.45B |
| Total current liabilities | 127.60M | 131.90M | 130.00M | 126.10M | 127.30M | 136.30M |
| Short-term debt | 4.10M | 4.20M | 4.10M | 3.90M | 4.00M | 4.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 240,100,000.00 | 244,600,000.00 | 243,300,000.00 | 234,200,000.00 | 233,800,000.00 | 241,700,000.00 |
| Total equity | 1.27B | 1.21B | 1.20B | 1.20B | 1.19B | 1.20B |
| Retained earnings | 1.18B | 1.11B | 1.11B | 1.12B | 1.12B | 1.14B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 66.82M | 161.32M | 165.06M | 124.40M | 129.50M | 131.40M | 127.10M | 101.20M |
| Depreciation & amortization | 50.07M | 49.16M | 71.43M | 43.30M | 45.90M | 51.10M | 49.40M | 54.30M |
| Free cash flow | 19.71M | 109.73M | 124.67M | 53.30M | 12.70M | 74.40M | 71.00M | 71.10M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.92M | 1.25M | 1.36M | 1.50M | -24.00M | 0 | -18.30M | -51.20M |
| Ending cash balance | 167.74M | 166.85M | 191.79M | 232.30M | 235.90M | 131.70M | 159.80M | 197.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 11.70M | 13.70M | 28.90M | 46.90M | 5.80M | 24.40M |
| Depreciation & amortization | 12.60M | 13.90M | 13.20M | 14.60M | 13.40M | 13.20M |
| Free cash flow | 2.10M | 5.60M | 21.20M | 42.20M | 1.10M | 18.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -10.00M | -13.80M | -- | -- |
| Ending cash balance | 175.60M | 157.20M | 167.80M | 197.00M | 195.80M | 181.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.86 | 5.31 | 5.12 | 10.11 | 10.18 | 4.66 | 2.08 | -5.05 |
| ROA %i | 7.29 | 3.71 | 3.94 | 7.56 | 7.19 | 3.58 | 1.74 | -4.25 |
| ROIC %i | 8.83 | 4.93 | 5.20 | 9.31 | 9.19 | 4.70 | 2.03 | -5.06 |
| 5-year avg ROE %i | 9.50 | 8.69 | 8.13 | 8.57 | 8.31 | 7.07 | 6.43 | 4.39 |
| EBIT margin %i | 12.59 | 7.01 | 9.45 | 13.78 | 15.43 | 9.54 | 4.32 | -5.41 |
| FCF / sales %i | 2.24 | 12.22 | 15.53 | 5.71 | 1.30 | 8.19 | 8.55 | 8.77 |
| Current ratioi | 4.53 | 4.63 | 4.25 | 3.56 | 4.63 | 4.53 | 4.00 | 3.97 |
| Quick ratioi | 3.17 | 3.15 | 3.19 | 2.65 | 3.20 | 2.95 | 2.62 | 2.86 |
| Debt / assetsi | 17.86 | 9.66 | 1.98 | 11.91 | 13.88 | 3.22 | 1.66 | 1.52 |
| LT debt / equityi | 26.93 | 13.17 | 2.45 | 17.00 | 19.25 | 3.61 | 1.65 | 1.50 |
| Interest coveragei | -- | 7.99 | 10.34 | 57.25 | 15.76 | 8.34 | 22.44 | -36.58 |
| Revenue CAGR (3Y) %i | 11.08 | 11.03 | -0.76 | 2.00 | 2.64 | 4.21 | -3.82 | -5.84 |
| Net income CAGR (3Y) %i | 23.69 | -0.67 | -14.67 | 7.24 | 35.07 | 4.23 | -37.73 | -- |
| FCF CAGR (3Y) %i | -26.23 | 3.55 | 3.71 | 39.33 | -51.27 | -15.81 | 10.03 | 77.56 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.34 | -5.25 | -5.34 | -5.05 | -4.54 | 2.60 |
| ROA %i | 1.13 | -4.41 | -4.48 | -4.25 | -3.81 | 2.16 |
| ROIC %i | 1.26 | -5.26 | -5.35 | -5.06 | -4.54 | 2.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.76 | -7.40 | -7.00 | -5.41 | -3.78 | 7.18 |
| FCF / sales %i | 6.74 | 6.43 | 5.89 | 8.77 | 8.54 | 9.92 |
| Current ratioi | 3.94 | 3.79 | 3.88 | 3.97 | 4.02 | 3.99 |
| Quick ratioi | 2.70 | 2.49 | 2.65 | 2.86 | 2.89 | 2.88 |
| Debt / assetsi | 1.60 | 1.63 | 1.59 | 1.52 | 1.51 | 1.42 |
| LT debt / equityi | 1.58 | 1.62 | 1.57 | 1.50 | 1.47 | 1.38 |
| Interest coveragei | 18.58 | -49.08 | -46.75 | -36.58 | -25.83 | 42.79 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Advanced Electronics Solutions is the largest reported line at 54.20% of revenue, across 3 reported segments.
- Elastomeric Material Solutions follows at 43.73%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Advanced Electronics Solutions54.20%
Elastomeric Material Solutions43.73%
Other2.08%
Quote time 2026-10-08 07:38:18 · For reference only, not investment advice and not tailored to your situation.